Person: Pierre Marc Johnson

Dr Peter Hackett

Dr Peter Hackett has been appointed president and CEO of the Alberta Ingenuity Fund (AIF), replacing Dr William Bridger, who is retiring. Hackett assumes the post in October, ending a long and illustrious, 32-year career at the National Research Council (NRC). Hackett was most recently the NRC’s VP research and his departure leaves two of…

Dr Gabe Kalmar

Dr Gabe Kalmar has been appointed Genome British Columbia’s executive director operations. Kalmar has a long track record of private sector experience in the pharmaceutical industry, most recently as a consultant working with several early-stage companies in the areas of technology development, merger and acquisition planning and operations. From 1996 to 2002, he held senior…

Pierre Marc Johnson

Pierre Marc Johnson has been appointed board chair of Saint-Laurent PQ-based Celmed BioSciences Inc, a spin-off of Theratechnologies. Johnson is the former premier of Quebec and has served as counsel to Heenan Blaikie since 1996. FMI on new board members see www.celmedbio.com….